INTENSIFIED CHEMOTHERAPY WITHOUT SCT IN INFANT ALL: RESULTS FROM COG P9407 (Cohort 3)

BACKGROUND: Infants with acute lymphoblastic leukemia (ALL) present with aggressive disease and a poor prognosis. Early relapse within 6–9 months of diagnosis is common. Approximately 75% of infants have MLL-rearranged (MLL-R) ALL with event free survival (EFS) ranging from 20–30%. Children’s Oncolo...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Pediatr Blood Cancer
Autori principali: Dreyer, ZoAnn E., Hilden, Joanne M., Jones, Tamekia L., Devidas, Meenakshi, Winick, Naomi J., Willman, Cheryl L., Harvey, Richard C., Chen, I-Ming, Behm, Fred G., Pullen, Jeanette, Wood, Brent L., Carroll, Andrew J., Heerema, Nyla A., Felix, Carolyn A., Robinson, Blaine, Reaman, Gregory H., Salzer, Wanda L., Hunger, Stephen P., Carroll, William L., Camitta, Bruce M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2014
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5145261/
https://ncbi.nlm.nih.gov/pubmed/25399948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25322
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi